Remed Co.,Ltd. (KOSDAQ:302550)
South Korea · Delayed Price · Currency is KRW 3,105.00
-60.00 (-1.90%)
At close: Feb 13, 2026
Remed Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 24,256 | 25,554 | 18,536 | 21,363 | 20,195 | 16,633 |
Other Revenue | -0 | -0 | - | - | -0 | - |
| 24,256 | 25,554 | 18,536 | 21,363 | 20,195 | 16,633 | |
Revenue Growth (YoY) | 3.55% | 37.86% | -13.23% | 5.79% | 21.41% | -10.33% |
Cost of Revenue | 9,980 | 11,508 | 9,589 | 10,293 | 9,880 | 8,057 |
Gross Profit | 14,275 | 14,046 | 8,947 | 11,071 | 10,315 | 8,576 |
Selling, General & Admin | 9,119 | 8,422 | 7,949 | 6,593 | 5,711 | 4,243 |
Research & Development | 3,720 | 3,483 | 2,940 | 2,426 | 2,731 | 2,288 |
Amortization of Goodwill & Intangibles | 89.6 | 97.71 | 98.73 | 90.89 | 71.99 | 24.57 |
Other Operating Expenses | 64.21 | 93.38 | 97.1 | 88.47 | 53.18 | 143.28 |
Operating Expenses | 13,851 | 12,925 | 11,807 | 9,410 | 9,192 | 6,892 |
Operating Income | 424.48 | 1,121 | -2,860 | 1,661 | 1,123 | 1,684 |
Interest Expense | -973.91 | -1,174 | -1,244 | -966.8 | -775.51 | -416.03 |
Interest & Investment Income | 372.9 | 444.54 | 847.53 | 687.73 | 706.26 | 232.96 |
Earnings From Equity Investments | 0 | -105.74 | -150.16 | -111.99 | -100.22 | -90.73 |
Currency Exchange Gain (Loss) | 445.1 | 668.74 | 334.91 | 272.88 | 542.56 | -701.49 |
Other Non Operating Income (Expenses) | 3,534 | 3,304 | -283.26 | 3,424 | -576.44 | -3,000 |
EBT Excluding Unusual Items | 3,803 | 4,259 | -3,355 | 4,967 | 919.81 | -2,291 |
Impairment of Goodwill | -268.88 | -268.88 | - | - | - | - |
Gain (Loss) on Sale of Investments | -50.27 | -343.93 | 342.47 | -336.6 | - | - |
Gain (Loss) on Sale of Assets | -93.07 | 4,400 | -0.01 | -70.63 | -36.72 | 11.92 |
Other Unusual Items | -30.29 | - | 3,992 | - | - | - |
Pretax Income | 3,360 | 8,045 | 979.66 | 4,560 | 883.08 | -2,279 |
Income Tax Expense | 77.52 | 664.59 | 660.41 | 608.71 | 130.75 | -445.46 |
Earnings From Continuing Operations | 3,283 | 7,381 | 319.24 | 3,951 | 752.33 | -1,834 |
Minority Interest in Earnings | -4.7 | -208.68 | 477.92 | 48.88 | - | - |
Net Income | 3,278 | 7,172 | 797.17 | 4,000 | 752.33 | -1,834 |
Net Income to Common | 3,278 | 7,172 | 797.17 | 4,000 | 752.33 | -1,834 |
Net Income Growth | -32.59% | 799.69% | -80.07% | 431.70% | - | - |
Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 31 | 30 |
Shares Outstanding (Diluted) | 34 | 33 | 31 | 31 | 31 | 30 |
Shares Change (YoY) | 9.70% | 9.33% | - | 0.35% | 1.84% | 14.35% |
EPS (Basic) | 106.59 | 234.09 | 26.02 | 130.56 | 24.64 | -61.17 |
EPS (Diluted) | 103.55 | 223.11 | 26.00 | 130.56 | 24.60 | -61.20 |
EPS Growth | -34.77% | 758.13% | -80.09% | 430.73% | - | - |
Free Cash Flow | -3,596 | 658.57 | 2,708 | 261.1 | -7,431 | 1,911 |
Free Cash Flow Per Share | -107.01 | 19.66 | 88.39 | 8.52 | -243.41 | 63.75 |
Gross Margin | 58.85% | 54.97% | 48.27% | 51.82% | 51.08% | 51.56% |
Operating Margin | 1.75% | 4.39% | -15.43% | 7.78% | 5.56% | 10.12% |
Profit Margin | 13.51% | 28.07% | 4.30% | 18.72% | 3.72% | -11.03% |
Free Cash Flow Margin | -14.83% | 2.58% | 14.61% | 1.22% | -36.80% | 11.49% |
EBITDA | 1,778 | 2,399 | -1,905 | 2,417 | 1,684 | 2,079 |
EBITDA Margin | 7.33% | 9.39% | -10.28% | 11.31% | 8.34% | 12.50% |
D&A For EBITDA | 1,354 | 1,278 | 954.51 | 755.6 | 560.7 | 395.47 |
EBIT | 424.48 | 1,121 | -2,860 | 1,661 | 1,123 | 1,684 |
EBIT Margin | 1.75% | 4.39% | -15.43% | 7.78% | 5.56% | 10.12% |
Effective Tax Rate | 2.31% | 8.26% | 67.41% | 13.35% | 14.81% | - |
Advertising Expenses | - | 535.11 | 725.79 | 420.15 | 299.26 | 70.05 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.